Hereditary angioedema in pregnancy and management without recombinant human C1-INH

A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-...

Full description

Bibliographic Details
Authors: Pilati, Natália Paseto, Zanatta, Maria Alexandrina, Maltauro, Daniele Camila, Behenck, Gabrielle, Valério, Edimárlei Gonsales, Castilhos, Fernanda Oliveira, Stuczynski, Eduardo Vettorazzi, Vettori, Daniela Vanessa, Vettorazzi, Janete
Format: article
Status:Published version
Publication Date:2021
Country:Brasil
Institution:Universidade Federal do Rio Grande do Sul (UFRGS)
Repository:Repositório Institucional da UFRGS
Language:English
OAI Identifier:oai:www.lume.ufrgs.br:10183/233244
Online Access:http://hdl.handle.net/10183/233244
Access Level:Open access
Keyword:Mulheres
Gravidez
Angioedemas hereditários
Gravidez de alto risco
Prevenção de doenças
Hereditary angioedema
HAE
C1-inhibitor
High-risk pregnancy
Prophylaxis
Description
Summary:A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-INH concentrate.